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Pemphigus foliaceus is a rare autoimmune
bullous dermatosis that can be induced by drugs,
with variable duration lasting between several weeks
and months. Erythematous scaly patches develop on
the scalp, face, neck or chest.1 The use of oral or
topical herbal supplements to improve health has
increased in the last decades. These preparations
may trigger multiple adverse effects, both cutaneous
and systematic.2
Hypericum perforatum (popularly known as St.
John’s wort) is an herbal drug with a widely known
photosensitizing effect and a possible immunomo-
dulatory effect.2,3
CASE REPORT
We present a 37-year-old woman, with no per-
sonal or family history of disease, who suffered from
an pruritic rash on her trunk for 2 months. Initial
lesions were small vesicles that rapidly developed
into crusted erosions. One week before the appear-
ance of skin lesions, she started taking St. John’s wort
orally (900 mg/d) as a remedy for fatigue associated
with insomnia.
Cutaneous examination found several erosive
crusted and well-defined patches with erythematous
edges on her lower neck and upper back (Figs 1 and
2). No lesions appeared on the limbs, face, cheeks,
mucous membranes, nails, and scalp. Nikolsky’s sign
was negative. After 1 week of treatment with
Amoxicillin-clavulanate, 875/125 mg (1 tablet every
8 hours), and topical mupirocin (twice daily), there
was no clinical improvement.
All the following laboratory evaluationswerewithin
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Case Reports 2016;2:326-8.blood cell count, white blood cell count, differential
count, urinalysis, erythrocyte sedimentation rate,
serum protein electrophoresis, quantitative serum
immunoglobulins, C3 and C4 levels, and rheumatoid
factor. The following tests were negative: antinuclear
antibodies, transglutaminase antibodies, antiedouble-
stranded DNA antibodies, and anti-Ro and anti-La
antibodies. Venereal Disease Research Laboratory,
hepatitis C, hepatitis B, HIV, and Mantoux tests were
negative.Chest radiographs andabdominal ultrasound
scans were taken with no pathologic findings.
A skin biopsy found an intra-epidermal blister
and inflammatory dermal infiltrate composed of
lymphocytes and eosinophils (Fig 3). Direct
immunofluorescence on perilesional skin found
deposits of IgG and C3 on keratinocytes’ surface
and along the dermo-epidermal junction (Fig 4).
Enzyme-linked immunosorbent assay screening
found a high titer of antidesmoglein 1 antibodies
(108 U/mL) and low titer of antidesmoglein 3
antibodies (0.85 U/mL).
According to the clinical and diagnostic features,
pemphigus foliaceus was diagnosed. Oral predni-
sone, 0.5 mg/kg/d and clobetasol propionate, 0.05%
cream daily were prescribed; however, within
1 month there was no clinical improvement.
Consequently, the patient was treated with azathio-
prine, 100 mg/d, and St. John’s wort use was
discontinued. After 2 months, the disease completely
resolved with no residual skin damage. Azathioprine2352-5126
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Fig 1. Crusted patch on her lower neck.
Fig 2. Pemphigus foliaceus. Scaly and crusted patches
with erythematous edges on her upper back.
Fig 3. Intraepidermal subcorneal blister with acantholytic
keratinocytes and eosinophils. Inflammatory superficial
dermal infiltrate composed of lymphocytes and eosino-
phils (Hematoxylin-eosin stain; original magnification:
320).
Fig 4. Direct immunofluorescence with deposits of
IgG and C3 on keratinocytes’ surface and along the
dermo-epidermal junction.
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patient had no new active skin lesions for 12 months,
during which she didn’t receive any treatment.
DISCUSSION
Topical and oral herbal supplements have been
associated with several skin diseases2-4 including
urticaria, angioedema, allergic contact dermatitis,
phototoxic rash, erythroderma, lichen planus,
Sweet’s syndrome, exudative erythema, Steven-
Johnson syndrome, erythema nodosum, palmoplan-
tar hyperkeratosis, skin ulcerations, and squamous
cell carcinoma. The development of autoimmune
diseases,5,6 such as pemphigus vulgaris, dermatomy-
ositis, and lupuslike syndrome, has been reported.Herbal supplements should be avoided during preg-
nancy or lactation and used with caution in patients
with reduced liver or kidney function.2-8
H perforatum derives from Hypericaceae family
plants and it has been used for more than 2000 years.
It has several biologically active substances, namely
hypericin and hyperforin. Other compounds include
flavonoids, quercetin, kaempferol, xanthones, and
bioflavonoids.3
H perforatum has been popularly used as a neuro-
protective agent, as an antioxidant, and as a treatment
for depression, anxiety, insomnia, water retention,
cuts, burns, viral and bacterial diseases, inflammatory
disorders, cancer, and opium dependence.3,7
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the majority being mild to moderate and transient.
The risk depends on several factors such as age, sex,
genetics, nutritional status, comorbidities, and
concurrent treatments.3,7
The most common adverse effects are gastroin-
testinal disturbances, allergic reactions, dizziness,
headache, confusion, restlessness, lethargy, and
dry mouth.3,7 A very common side effect is photo-
toxicity3,7,9 secondary to high doses of hypericin
($ 0.5 mg/kg). The hypericin can absorb the ultra-
violet light and the visible part of the electromagnetic
spectrum. Phototoxicity can potentially induce eye
damage and a pruritic skin rash. Phototoxicity is
caused by photo-oxidation of components of the cell
membrane (hypericin and pseudohypericin),
causing active forms of oxygen including singlet
oxygen, superoxide and hydroxyl radicals, and
peroxides. Hypericin has been used as photosensi-
tizer for photodynamic therapy of skin neoplasms.9
H perforatum may interact with other drugs. It
can induce intestinal P-glycoprotein and liver
cytochrome P450s (CYPs), including CYP2C9 and
CYP3A4.3,7,8,10
Therefore, H perforatum may reduce the efficacy
of the oral contraceptive pill, warfarin, proton-pump
inhibitors, antihypertensives, benzodiazepines,
immunosuppressants, digoxin, theophylline, carba-
mazepine, HIV medication (protease inhibitor),
fluoroquinolones, tetracyclines, and analgesics.
Moreover, H perforatum may potentiate the adverse
effects of anesthetics, opioid, antidepressants (sero-
tonin-specific reuptake inhibitors) and antidiabetic
agents.3,7,8,10
Autoimmune diseases2-7 may be triggered by
an immune-enhancing effect. Herbal supplements
may increase activity of macrophages, neutrophils,
natural killer cells, and proinflammatory cytokines
levels such as interleukin-1 and tumor necrosisfactorealpha. However, the mechanisms of action
remain unknown.
Herbal supplements should be considered med-
ications and health professionals should be aware of
their potential adverse effects and drug interactions.
Herbal supplements may have an immune-
enhancing effect, exacerbating preexisting autoim-
mune diseases or triggering autoimmune disease in
genetically predisposed individuals.2-7 As a result, a
complete drug history is necessary. In our case,
pemphigus foliaceus onset was temporally
associated with the use of H perforatum, but cause
and effect cannot be proven. Further studies are
needed to investigate the effect of herbal drugs in
pemphigus and other autoimmune diseases.REFERENCES
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